Comparison of the Postoperative Analgesic Effects of SPSIPB and TPB in Mastectomy Operations
- Conditions
- MastectomyPeripheral Nerve BlockPain Management
- Registration Number
- NCT06789146
- Lead Sponsor
- Ankara Etlik City Hospital
- Brief Summary
Breast cancer is the most common malignancy in women, and surgery is one of the cornerstone treatments for breast cancer. Postoperative pain can significantly reduce patients' quality of life and acute pain may even trigger chronic pain syndrome.
Nerve blocks reduces opioid consumption in the postoperative period by providing better pain control and therefore has advantages such as fewer side effects and less risk of pulmonary and cardiac complications.
In this study; it was aimed to compare the analgesic effectiveness of serratus posterior superior intercostal plane block and thoracic paravertebral block in the postoperative period in patients who underwent mastectomy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 60
- Patients aged 18-80 years
- American Society of Anesthesiologists (ASA) score I-II-III
- Body Mass Index (BMI) between 18-30 kg/m2
- Patients under 18 and over 80 years of age
- ASA score IV and above
- Patients with a history of bleeding diathesis
- BMI below 18 or above 30 kg/m2
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Pain Scores On the operation day Pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 10 (worst pain). Pain assessment will be done at 0st, 1st, 2nd,4th, 12th, and 24th hours after surgery.
- Secondary Outcome Measures
Name Time Method Intraoperative opioid consumption Intraoperative period Remifentanil consumption for intraoperative period will be recorded
Postoperative Tramadol Consumption On the operation day Tramadol consumption for 24 hours will be recorded
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Ankara Etlik City Hospital
🇹🇷Yenimahalle, Ankara, Turkey
Ankara Etlik City Hospital🇹🇷Yenimahalle, Ankara, TurkeyAtakan Sezgi, MDContact00905323327000kansezgi@gmail.comMustafa Sırrı Kotanoğlu, Associate ProfessorContact00905322514979mskotan@gmail.com